Clinical trials: for Bowel Dysfunction Following Surgery for Rectal Cancers

Rectal Cancer, for Bowel Dysfunction Following Surgery for Rectal Cancers

Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

• Terminated
• Age: 18 years and older
• Phase 2/3
• Medical device
• Lifestyle or therapy programme
• Results posted

The purpose of this study is to evaluate whether a medical device/implant (InterStimTM) will help patients to have more normal bowel movements. The InterStimTM device is a neuromodulating device.

Trial name

NCT02163187

Testing

Implantation of the InterStimTM, MSK BFI questionnaires, The Low Anterior Resection Score (LARS) questionnaires

Where

2 sites in United States

Volunteers

4 people

Sponsor

Memorial Sloan Kettering Cancer Center